Related Experiment Video
Updated: Aug 5, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 9, 2014
Expression, purification and bioactivity characterization of extracellular domain of murine osteoprotegerin ligand
Bao-Li Wang1, Ming-Cai Qiu, Gang Guo
1Key Laboratory of Hormone and Development of the Public Health Ministry, Tianjin Medical University Hospital, Tianjin Institute of Endocrinology, Tianjin 300052, China. bliwang@163.net
Abstract:
Osteoprotegerin ligand (OPGL) is a key regulator of formation and activation of osteoclasts. In the present study, the cDNA encoding the extracellular domain of murine OPGL (sOPGL) was synthesized by RT-PCR and cloned into fusion expression vector pET-42a(+) in a certain strategy on purpose that the fusion tag could be completely removed by factor Xa from the expressed fusion protein without any vector-encoded sequence left. Induced with IPTG, the recombinant E. Coli cells produced a 47 kD protein in high level that could be recognized, through Western blotting analysis, by the antibody against OPGL. The expressed products were purified through Glutathione-sepharose 4B affinity chromatography. Along with the fusion molecule, a protein about 30 kD was also specifically bound to the resin. The 30 kD molecule could be recognized by polyclonal antibody against GST-IGF-1, but not by antibody against OPGL. It suggested that the 30 kD molecule was derived from the degradation of the fusion protein. After the cleavage with factor Xa and further purification, the fusion tag was removed and the recombinant sOPGL was obtained. Finally, we confirmed that the recombinant sOPGL could promote osteoclast formation from mouse bone marrow cells in a dose dependent manner.

